← Back to Search

Engagement Strategies for Suicidal Thoughts

N/A
Waitlist Available
Led By Shari Jager-Hyman, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is looking at what keeps suicidal patients from going to their first mental health visit, and trying to come up with ways to get them there.

Who is the study for?
This trial is for adults who can read and understand English, have shown signs of suicidal thoughts during a primary care visit, and are considered able to attend mental health treatment. It's not for those with current severe psychosis, dementia diagnosed in the last 2 years, or those already engaged in a similar study strategy.Check my eligibility
What is being tested?
The trial aims to identify why some at-risk individuals skip their first mental health appointment after referral and develop strategies to encourage attendance. This involves using data analysis, expert collaboration, and testing methods from behavioral economics and implementation science.See study design
What are the potential side effects?
Since this trial focuses on engagement strategies rather than medical interventions, traditional side effects are not applicable. However, participants may experience discomfort discussing sensitive topics or stress from engaging in new treatment processes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention Measure (AIM)
Attendance at first mental health visit
Feasibility of Intervention Measure (FIM)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Engagement strategy groupsExperimental Treatment1 Intervention
We anticipate that approximately 25 patients will receive an engagement strategy (~5 patients per strategy; only 1 strategy per patient). The exact strategies will be developed during the course of this R21 and cannot yet be specified. This is a non-control, pilot feasibility trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rapidly prototype and test strategies
2022
N/A
~30

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,880,066 Total Patients Enrolled
16 Trials studying Suicide
57,491 Patients Enrolled for Suicide
Shari Jager-Hyman, PhDPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
1,665 Total Patients Enrolled
1 Trials studying Suicide
1,665 Patients Enrolled for Suicide
Courtney Benjamin Wolk, PhDPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
80 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots available in this research trial?

"According to clinicaltrials.gov, this trial is not currently recruiting subjects. The experimentation has been posted since March 7th 2022 and was last edited on June 27th 2022. Although the study cannot accept participants at this time, there are 1314 other trials actively seeking enrolment from volunteers."

Answered by AI

Is there any possibility that I might qualify to join this research project?

"This clinical trial is accepting applications from individuals aged between 18 and 100 who have dealt with suicidal ideation. 25 participants are required to move the study forward."

Answered by AI

Does this trial offer participation to individuals aged 40 and above?

"This trial will accept participants aged 18 to 100 years old. There are 237 studies for younger patients and 965 clinical trials enrolling those over 65."

Answered by AI
~7 spots leftby Apr 2025